Nature

Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial

This was a randomized, monocentric, non-blinded, phase II trial recruiting from September 2018 to December 2022 at the University Hospital of Bern, Switzerland. The study had approval by the local ...
Nature

Machine learning-based prediction of G-CSF-induced hematopoietic stem cell mobilization outcomes in healthy volunteers

Haematopoietic stem cell transplantation (HSC-T) has been established as a fundamental therapeutic intervention for a wide range of hematological malignancies and disorders, with a proven record of ...